Keep Your Balance<br />By Rev Shark<br />RealMoney.com Contributor<br />6/2/2009 8:47 AM EDT <br /><br />"Life is like riding a bicycle. To keep your balance, you must keep moving" <br /><br />-- Albert Einstein <br />On Monday, the market experienced exceptionally positive action. We broke out of a trading range, the point gain was big, breadth was excellent and volume heavy. That is how a healthy market is supposed to act. <br /><br />It would seem that the proper thing to do is just embrace your inner bull and enjoy the ride higher, but it is never quite that easy. When we have so much celebration of the wonderfulness of it all and so many stocks that are technically extended after a number of big days in a row, it is extremely important that we stay balanced. <br /><br />The one great certainty of the market is that it won't go straight up or down, and the easiest way to lose money is to not appreciate that even within a strong trend there will be bumps along the way. There is nothing at all wrong with this market technically other than a surplus of exuberance and some extended charts, so there is no reason to be overly negative. On the other hand, the complacency and the lack of fear suggest that it is dangerous to keep chasing stocks that have already jumped sharply and have not consolidated. <br /><br />No trader is totally objective when looking at the market. If you own a stock, you are always going to have some sort of bias as you are looking for the market to move in a certain way. The important thing is to recognize that and consciously try to balance your natural inclination. Too often, people do just the opposite. Rather than look for flaws in their thinking they dismiss anything that contradicts it and seek out only those things that confirm it. <br /><br />Having a balanced view of the market is not an easy thing to do because the market itself is so prone to extremes. It rarely acts like a rational person. It will always move higher or lower than you think is reasonable. So while you want to always consider both the bullish and bearish views, you also must remember that you are dealing with crowd psychology, and it is can't be reduced to a mathematical formula. <br /><br />Let's appreciate the fact that the market looks pretty good technically, but let's maintain our balance and also appreciate that we are unlikely to go straight up without pause. Don't get carried away in the celebration. Make sure you don't forget to protect positions and take some gains. <br /><br />We have a slightly soft open as overseas markets cooled a bit and investors consider a secondary offering from JPMorgan Chase (JPM) . We need some consolidation after the late surge Friday and the strength yesterday, but I suspect the dip buyers will be anxious to do their thing. <br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: NAVR +45.6%, ONAV +8.0%, UNFI +6.4%... M&A news: HLND +30.7% and HPGP +20.3% (to be acquired by affiliates of Harold Hamm; Hiland Partners' unitholders will receive $7.75/common unit they hold and Hiland Holdings' unitholders will receive $2.40/common unit they hold), NTG +12.6% (Cameron to acquire NATCO in all-stock transaction; NTG shareholders to receive 1.185 CAM shares for each NTG share), DDUP +12.0% (EMC proposes to acquire Data Domain for $30/share in cash; this follows NTAP's $25/share stock and cash bid from 5/20)... Select European financials trading higher: AIB +6.7%, IRE +2.5%... Select gold related names showing strength: GOLD +2.7%, HMY +2.2%, AEM +1.3%... Select shippers showing strength boosted by ONAV results: FRO +3.0%, DRYS +2.9%, EXM +2.4%... Other news: CLDA +21.4% (announces positive results from second Ph. 3 trial of vilazodone for depression), CYTK +17.4% (presents clinical data relating to Ispinesib; says Ispinesib appears to demonstrate anti-cancer activity with a similar toxicity profile when compared with prior trials), VLNC +14.0% (announces MOU with Siemens to develop batteries compatible with Siemens' Marine Hybrid Propulsion Systems), CRGN +12.2% (updates CR011-vcMMAE data at ASCO), SAY +8.8% (says its automotive business won't be hit by GM bankruptcy filing - Dow Jones), PARD +7.0% (still checking), GA +5.4% (still checking), ALVR +4.7% (announced it was chosen by Mobitel to provide 802.16e WiMAX services for under-served areas throughout Nigeria), DV +4.7% (GM's place in the S&P 500 will be taken by S&P MidCap 400 constituent DeVry), CAL +4.5% (reports May 2009 operational performance; also upgraded to Overweight at JPMorgan), STM +4.3% (still checking for anything specific)... Analyst comments: UFS +10.7% (upgraded to Outperform from Neutral at Credit Suisse), MDZ +8.8% (upgraded to Buy at Jefferies), ISRG +2.4% (upgraded to Buy at Needham), EJ +2.1% (upgraded to Outperform at Credit Suisse), GTI +1.8% (initiated with a Buy at Canaccord), NETL +1.5% (upgraded to Buy at Piper). <br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance: DAKT -15.4% (light volume), LAYN -11.0% (light volume), LGF -4.6%, ENS -4.2% (light volume), BLUD -4.0%... M&A news: CAM -2.1% (Cameron to acquire NATCO in all-stock transaction; NTG shareholders to receive 1.185 CAM shares for each NTG share)... Select financials showing weakness: BCS -12.0% (Middle East fund selling large stake in Barclays - NY Times), KEY -4.6%, MS -3.0% (announces $2.2 billion public offering of common equity), C -2.7% (Citigroup is halting some payouts - WSJ), CIT -2.6%, DB -2.5%, JPM -2.3% (confirms pricing of 142 mln shares of common stock at $35.25/share), STI -2.2% (prices 108 mln common share offering at $13.00/share), HBC -2.1%, FITB -2.0%, WFC -1.9%, AXP -1.5% (announces $500 mln common stock offering), ABB -1.3%, UBS -1.1%... Select large cap drug names trading lower: NVS -2.9%, GSK -1.8%, AZN -1.8%, SNY -1.0%... Other news: MTZ -9.8% (announces offerings to refinance convertible notes and sell common stock for prior acquisition related shareholders), GM -8.0% (will be removed from the S&P 500 index; also announces preliminary agreement to sell HUMMER), CBL -7.9% (determined to reduce the dividend for the remainder of 2009 to the minimum level required to distribute 100% of the co's estimated taxable income), DCT -6.0% (announces commencement of public offering of 22.5 mln shares of common stock), IRET -5.5% (announces public offering of 3 mln common shares of beneficial interest), ICON -4.9% (announces follow-on equity offering of 9.2 mln shares and selling stockholders will offer 800,000 shares), BKD -4.8% (announces public offering of $150 mln of common stock), RZ -3.5% (announced that it has filed a universal shelf registration of $150 mln in mixed securities), IO -3.3% (announces a private placement offering of 18.5 mln shares of common stock priced at $2.20/share), IMAX -3.1% (prices 9.8 mln common share offering at $7.15/share), ERIC -2.5% (still checking for anything specific), QSFT -2.4% (announces intent to commence modified dutch auction to repurchase 10.715 mln shares of its common stock)... Analyst comments: MTH -4.4% (downgraded to Sell at UBS), JNPR -4.1% (downgraded to Neutral at UBS), CHL -4.0% (removed from Conviction Buy List by Goldman- DJ), TECD -2.1% (resumed with a Sell at Goldman- Reuters), MICC -2.0% (downgraded to Outperform from Strong Buy at Raymond James), MTL -1.3% (downgraded to Equal Weight at Morgan Stanley).